Studies suggest that as many as 75% of patients on IFN report one or more psychiatric side effects including depression, anxiety, insomnia, and impaired concentration [10,11], and approximately 20% – 30% meet criteria for IFN-induced major depressive disorder [12,13]. Here, IFNA1 is linked to insomnia.